Literature DB >> 12523496

Regulation of glucose transport in human skeletal muscle.

H A Koistinen1, J R Zierath.   

Abstract

Glucose transport, the rate limiting step in glucose metabolism in skeletal muscle, is mediated by insulin-sensitive glucose transporter 4 (GLUT4) and can be activated in skeletal muscle by two separate and distinct signalling pathways: one stimulated by insulin and the second by muscle contractions. Skeletal muscle is the principal tissue responsible for insulin-stimulated glucose disposal and thus the major site of peripheral insulin resistance. Impaired glucose transport in skeletal muscle leads to impaired whole body glucose uptake, and contributes to the pathogenesis of Type 2 diabetes mellitus. A combination of genetic and environmental factors is likely to contribute to the pathogenesis of Type 2 diabetes mellitus; however, the primary defect is still unknown. Intense efforts are underway to define the molecular mechanisms that regulate glucose metabolism in insulin sensitive tissues. This review will present our current understanding of mechanisms regulating glucose transport in skeletal muscle in humans. Elucidation of the pathways involved in the regulation of glucose homeostasis will offer insight into the pathogenesis of insulin resistance and Type 2 diabetes mellitus and may lead to the identification of biochemical entry points for drug intervention to improve glucose homeostasis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12523496     DOI: 10.1080/078538902321012351

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  32 in total

Review 1.  Staying alive: metabolic adaptations to quiescence.

Authors:  James R Valcourt; Johanna M S Lemons; Erin M Haley; Mina Kojima; Olukunle O Demuren; Hilary A Coller
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

2.  Insulin resistance for glucose uptake and Akt2 phosphorylation in the soleus, but not epitrochlearis, muscles of old vs. adult rats.

Authors:  Naveen Sharma; Edward B Arias; Mini P Sajan; James G MacKrell; Abhijit D Bhat; Robert V Farese; Gregory D Cartee
Journal:  J Appl Physiol (1985)       Date:  2010-03-25

3.  Temporal profiling of the transcriptional basis for the development of corticosteroid-induced insulin resistance in rat muscle.

Authors:  Richard R Almon; Debra C Dubois; Jin Y Jin; William J Jusko
Journal:  J Endocrinol       Date:  2005-01       Impact factor: 4.286

4.  Relationships between circadian rhythms and modulation of gene expression by glucocorticoids in skeletal muscle.

Authors:  Richard R Almon; Eric Yang; William Lai; Ioannis P Androulakis; Svetlana Ghimbovschi; Eric P Hoffman; William J Jusko; Debra C Dubois
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-07-30       Impact factor: 3.619

5.  Troglitazone causes acute mitochondrial membrane depolarisation and an AMPK-mediated increase in glucose phosphorylation in muscle cells.

Authors:  D Konrad; A Rudich; P J Bilan; N Patel; C Richardson; L A Witters; A Klip
Journal:  Diabetologia       Date:  2005-04-15       Impact factor: 10.122

6.  Control of muscle glucose uptake: test of the rate-limiting step paradigm in conscious, unrestrained mice.

Authors:  Patrick T Fueger; Jane Shearer; Deanna P Bracy; Kelly A Posey; R Richard Pencek; Owen P McGuinness; David H Wasserman
Journal:  J Physiol       Date:  2004-12-02       Impact factor: 5.182

7.  Muscle-Specific Insulin Receptor Overexpression Protects Mice From Diet-Induced Glucose Intolerance but Leads to Postreceptor Insulin Resistance.

Authors:  Guoxiao Wang; Yingying Yu; Weikang Cai; Thiago M Batista; Sujin Suk; Hye Lim Noh; Michael Hirshman; Pasquale Nigro; Mengyao Ella Li; Samir Softic; Laurie Goodyear; Jason K Kim; C Ronald Kahn
Journal:  Diabetes       Date:  2020-08-31       Impact factor: 9.461

Review 8.  Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus.

Authors:  Cornelia B Landersdorfer; William J Jusko
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

9.  [Renal denervation: current state and future perspectives].

Authors:  K Kara; H Bruck; P Kahlert; B Plicht; A A Mahabadi; T Konorza; R Erbel
Journal:  Herz       Date:  2012-11       Impact factor: 1.443

10.  Insulin resistance in skeletal muscles of caveolin-3-null mice.

Authors:  Jin Oshikawa; Koji Otsu; Yoshiyuki Toya; Takashi Tsunematsu; Raleigh Hankins; Jun-ichi Kawabe; Susumu Minamisawa; Satoshi Umemura; Yasuko Hagiwara; Yoshihiro Ishikawa
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.